Soluble Suppression of Tumorigenicity 2 is Directly Correlated with Glycated Hemoglobin in Individuals with an Average glycemia in the Normal/Prediabetes Range
Amal Hasan,1 Waleed Aldhahi2,3 1Department of Immunology and Microbiology, Dasman Diabetes Institute, Kuwait City, Kuwait; 2Medical Division, Dasman Diabetes Institute, Kuwait City, Kuwait; 3Department of Medicine, Mubarak Al-Kabeer Hospital, Kuwait City, KuwaitCorrespondence: Amal Hasan Email amal....
Guardado en:
Autores principales: | Hasan A, Aldhahi W |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb185f3232844568b64569c92d25b541 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correlation Profile of Suppression of Tumorigenicity 2 and/or Interleukin-33 with Biomarkers in the Adipose Tissue of Individuals with Different Metabolic States
por: Hasan A, et al.
Publicado: (2020) -
Traditional probiotic (Kefir) effects on glycated hemoglobin a level and weight of an indexed diabetic patient
por: Hasan Hosainzadegn, et al.
Publicado: (2021) -
Glycated hemoglobin test: diagnostic difficulties in gestational diabetes
por: Tatiana Vladimirovna Saprina, et al.
Publicado: (2012) -
Diagnostic and Prognostic Value of Glycated Hemoglobin (HbA1c) in Patients with Diabetes Mellitus and Thalassemia
por: Yordanov E., et al.
Publicado: (2020) -
GLYCATED HEMOGLOBIN AS A BIOMARKER TO PREDICT DYSLIPIDEMIA IN TYPE 2 DIABETES MELLITUS
por: Abdul Moueed Tariq, et al.
Publicado: (2020)